Now showing items 1-2 of 2
Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: Translational implications
(NRC Research Press, 2018-11)
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to prevent heart failure and reduce cardiovascular death in patients with type 2 diabetes (T2DM) and cardiovascular disease (CVD). Whether or not SGLT2 ...
Exercise Capacity in Patients with The Total Artificial Heart
(Lippincott, Williams & Wilkins, 2019-01)
There is a dearth of information regarding the functional abilities of patients with the total artificial heart (TAH). Increased utilization of the TAH and patient discharge to home with the portable unit necessitates a ...